Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vincenzo Narciso"'
Autor:
Vito Di Marco, Vincenza Calvaruso, Salvatore Petta, Mariarosaria Saturnino, Riccardo Nevola, Pia Clara Pafundi, Ferdinando Carlo Sasso, Carmine Coppola, Graziano Troina, Aldo Marrone, Francesca Rini, Laura Staiano, Anna Ludovica Fracanzani, Barbara Guerrera, Mauro Giordano, Luigi Elio Adinolfi, Vincenzo Narciso, Rosa Lombardi, Luca Rinaldi, Antonio Craxì, Antonio Solano
Publikováno v:
Atherosclerosis. 296:40-47
Background and aims: HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV disease is poorly understood. We investigate whether HCV eradication reduces CV e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66db58249ecddb89e56032a7daead55b
https://doi.org/10.1016/j.atherosclerosis.2020.01.010
https://doi.org/10.1016/j.atherosclerosis.2020.01.010
Autor:
Ferdinando Carlo Sasso, Salvatore Petta, Antonio Solano, Vito Di Marco, Luigi Elio Adinolfi, Luca Rinaldi, Aldo Marrone, Riccardo Nevola, Graziano Troina, Mauro Giordano, Anna Ludovica Fracanzani, Antonio Craxì, Mariarosaria Saturnino, Pia Clara Pafundi, Francesca Rini, Laura Staiano, Carmine Coppola, Barbara Guerrera, Vincenza Calvaruso, Rosa Lombardi, Vincenzo Narciso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dc449795a23f249f7a62f359385ccda
https://doi.org/10.1111/dom.14168/v2/response1
https://doi.org/10.1111/dom.14168/v2/response1
Autor:
Antonio Solano, Anna Ludovica Fracanzani, Ferdinando Carlo Sasso, Salvatore Petta, Pia Clara Pafundi, Antonio Craxì, Riccardo Nevola, Barbara Guerrera, Carmine Coppola, Vito Di Marco, Rosa Lombardi, Vincenzo Narciso, Aldo Marrone, Vincenza Calvaruso, Luigi Elio Adinolfi, Luca Rinaldi, Mariarosaria Saturnino, Mauro Giordano, Francesca Rini, Laura Staiano, Graziano Troina
Aim HCV infection increases the risk of type 2 diabetes mellitus (T2DM). However, it remains still unclear whether HCV clearance by direct-acting antivirals (DAA) reduces T2DM. Therefore, the effect of HCV eradication on T2DM incidence was assessed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f86f20614d9d74ecd378aeb7239ce5a0
http://hdl.handle.net/10447/509988
http://hdl.handle.net/10447/509988
Autor:
Antonio Ascione, null CLEO Study Group, Luigi Elio Adinolfi, Pietro Amoroso, Angelo Andriulli, Orlando Armignacco, Tiziana Ascione, Sergio Babudieri, Giorgio Barbarini, Michele Brogna, Francesco Cesario, Vincenzo Citro, Ernesto Claar, Raffaele Cozzolongo, Giuseppe D’Adamo, Emilio D’Amico, Pellegrino Dattolo, Massimo De Luca, Vincenzo De Maria, Massimo De Siena, Giuseppe De Vita, Antonio Di Giacomo, Rosanna De Marco, Giorgio De Stefano, Giulio De Stefano, Sebastiano Di Salvo, Raffaele Di Sarno, Nunzia Farella, Laura Felicioni, Basilio Fimiani, Luca Fontanella, Giuseppe Foti, Caterina Furlan, Francesca Giancotti, Giancarlo Giolitto, Tiziana Gravina, Barbara Guerrera, Roberto Gulminetti, Angelo Iacobellis, Michele Imparato, Angelo Iodice, Vincenzo Iovinella, Antonio Izzi, Alfonso Liberti, Pietro Leo, Gennaro Lettieri, Ileana Luppino, Aldo Marrone, Ettore Mazzoni, Vincenzo Messina, Roberto Monarca, Vincenzo Narciso, Lorenzo Nosotti, Adriano Maria Pellicelli, Alessandro Perrella, Guido Piai, Antonio Picardi, Paola Pierri, Grazia Pietromatera, Francesco Resta, Luca Rinaldi, Mario Romano, Angelo Rossini, Maurizio Russello, Grazia Russo, Rodolfo Sacco, Vincenzo Sangiovanni, Antonio Schiano, Antonio Sciambra, Gaetano Scifo, Filomena Simeone, Annarita Sullo, Pierluigi Tarquini, Paolo Tundo, Alfredo Vallone
Publikováno v:
World Journal of Hepatology. 8:949
AIM:To check the safety and efficacy of boceprevir/telaprevir with peginterferon/ribavirin for hepatitis C virus (HCV) genotype 1 in the real-world settings. METHODS: This study was a non-randomized, observational, prospective, multicenter. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d28bc99042ad82c395e2080c1e67a32
https://doi.org/10.4254/wjh.v8.i22.949
https://doi.org/10.4254/wjh.v8.i22.949